Pohang, South Korea

Bum Jin Kim

This inventor holds 1 USPTO granted patent. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bum Jin Kim. Retrieved from https://idiyas.com/inventor/bum-jin-kim-t3155ntc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bum Jin Kim - Innovator in Drug Delivery Systems

Introduction

Bum Jin Kim is a notable inventor based in Pohang-si, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative use of pH-responsive nanoparticles.

Latest Patents

His most recent patent is titled "PH-responsive nanoparticle using mussel adhesive protein for drug delivery and method for preparing the same." This invention focuses on a pH-responsive metal-catechol derivative nanoparticle designed for drug delivery, utilizing mussel adhesive protein. Specifically, the patent describes the Fe(III)-DOPA nanoparticle, which demonstrates excellent biocompatibility and the ability to penetrate target cells efficiently. The nanoparticle is engineered to release its drug payload under acidic conditions, allowing for selective delivery to diseases characterized by an acidic environment.

Career Highlights

Bum Jin Kim is affiliated with the Postech Academy-Industry Foundation, where he continues to advance research in innovative drug delivery methods. His work has garnered attention for its potential applications in medical treatments.

Collaborations

He has collaborated with notable colleagues, including Hyung Joon Cha and Ho Gyun Cheong, contributing to the advancement of research in his field.

Conclusion

Bum Jin Kim's innovative work in developing pH-responsive nanoparticles represents a significant advancement in drug delivery technology. His contributions are poised to enhance targeted therapies for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…